2.64
price up icon2.72%   0.07
after-market Handel nachbörslich: 2.61 -0.03 -1.14%
loading
Schlusskurs vom Vortag:
$2.57
Offen:
$2.56
24-Stunden-Volumen:
57,099
Relative Volume:
0.85
Marktkapitalisierung:
$331.49M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-63.68M
KGV:
-5.617
EPS:
-0.47
Netto-Cashflow:
$-54.15M
1W Leistung:
-4.69%
1M Leistung:
-2.58%
6M Leistung:
-1.86%
1J Leistung:
-8.01%
1-Tages-Spanne:
Value
$2.5491
$2.69
1-Wochen-Bereich:
Value
$2.46
$2.82
52-Wochen-Spanne:
Value
$2.19
$3.4547

Nautilus Biotechnology Inc Stock (NAUT) Company Profile

Name
Firmenname
Nautilus Biotechnology Inc
Name
Telefon
206-333-2001
Name
Adresse
2701 EASTLAKE AVE EAST, SEATTLE
Name
Mitarbeiter
161
Name
Twitter
Name
Nächster Verdiensttermin
2024-10-29
Name
Neueste SEC-Einreichungen
Name
NAUT's Discussions on Twitter

Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-01-06 Eingeleitet Morgan Stanley Equal-Weight
2021-11-02 Eingeleitet Cowen Outperform
2021-08-04 Eingeleitet Goldman Neutral
2021-07-13 Eingeleitet Jefferies Buy

Nautilus Biotechnology Inc Aktie (NAUT) Neueste Nachrichten

pulisher
Oct 31, 2024

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award - Quantisnow

Oct 31, 2024
pulisher
Oct 31, 2024

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 31, 2024
pulisher
Oct 31, 2024

Nautilus Biotechnology Co-founder and Chief Scientist Parag - GlobeNewswire

Oct 31, 2024
pulisher
Oct 31, 2024

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award - StockTitan

Oct 31, 2024
pulisher
Oct 31, 2024

Nautilus Biotechnology Reports Q3 2024 Financial Results - MSN

Oct 31, 2024
pulisher
Oct 31, 2024

Nautilus Biotechnology Faces ESG Challenges Amid Regulatory Pressure and Investor Scrutiny - TipRanks

Oct 31, 2024
pulisher
Oct 30, 2024

Glass House Brands to Host Third Quarter 2024 Conference Call on November 13, 2024 - The Manila Times

Oct 30, 2024
pulisher
Oct 30, 2024

Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference - GlobeNewswire

Oct 30, 2024
pulisher
Oct 30, 2024

SG Americas Securities LLC Takes Position in Cardlytics, Inc. (NASDAQ:CDLX) - Defense World

Oct 30, 2024
pulisher
Oct 29, 2024

Nautilus Biotechnology Reports Third Quarter 2024 Financial Results - GlobeNewswire

Oct 29, 2024
pulisher
Oct 29, 2024

Nautilus Biotechnology reports Q3 EPS (13c), consensus (16c) - TipRanks

Oct 29, 2024
pulisher
Oct 22, 2024

Nautilus Biotechnology (NAUT) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat

Oct 22, 2024
pulisher
Oct 12, 2024

Renaissance Technologies LLC Decreases Stock Holdings in Immix Biopharma, Inc. (NASDAQ:IMMX) - Defense World

Oct 12, 2024
pulisher
Oct 12, 2024

Renaissance Technologies LLC Acquires 9,459 Shares of Toro Corp. (NASDAQ:TORO) - Defense World

Oct 12, 2024
pulisher
Oct 12, 2024

Renaissance Technologies LLC Has $358,000 Stock Holdings in Standard Lithium Ltd. (NYSE:SLI) - Defense World

Oct 12, 2024
pulisher
Oct 12, 2024

Renaissance Technologies LLC Cuts Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK) - Defense World

Oct 12, 2024
pulisher
Oct 10, 2024

Nautilus Biotechnology Inc. - Scrip

Oct 10, 2024
pulisher
Oct 09, 2024

We Think Nautilus Biotechnology (NASDAQ:NAUT) Can Afford To Drive Business Growth - Yahoo Finance

Oct 09, 2024
pulisher
Oct 08, 2024

Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024 - The Manila Times

Oct 08, 2024
pulisher
Oct 04, 2024

nautilus biotechnology, inc. Earnings dates - RTTNews

Oct 04, 2024
pulisher
Sep 29, 2024

Clearline Capital LP Lowers Stake in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Sep 29, 2024
pulisher
Sep 27, 2024

Tech Moves: GE healthcare exec joins startup; Nautilus taps new CMO; WRF investor steps down - MSN

Sep 27, 2024
pulisher
Sep 25, 2024

Insider Selling: Nautilus Biotechnology, Inc. (NASDAQ:NAUT) VP Sells 47,031 Shares of Stock - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Nautilus Biotechnology senior VP sells over $134k in company stock - Investing.com

Sep 25, 2024
pulisher
Sep 25, 2024

Caxton Associates LP Acquires 131,589 Shares of Entegris, Inc. (NASDAQ:ENTG) - Defense World

Sep 25, 2024
pulisher
Sep 20, 2024

2 Kite vets fly over to Kyverna Therapeutics—Chutes & Ladders - Fierce Biotech

Sep 20, 2024
pulisher
Sep 19, 2024

Nautilus Biotechnology senior VP sells shares worth over $99k - Investing.com India

Sep 19, 2024
pulisher
Sep 18, 2024

Nautilus Biotechnology senior VP sells shares worth over $99k By Investing.com - Investing.com Canada

Sep 18, 2024
pulisher
Sep 17, 2024

Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer | Daily - Daily Guardian Canada

Sep 17, 2024
pulisher
Sep 17, 2024

Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer - GlobeNewswire

Sep 17, 2024
pulisher
Sep 11, 2024

Nautilus Biotechnology, Inc.'s (NASDAQ:NAUT) Top Key Executive Parag Mallick is the most upbeat insider, and their holdings increased by 11% last week - Simply Wall St

Sep 11, 2024
pulisher
Sep 07, 2024

Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Down 0.8% - MarketBeat

Sep 07, 2024
pulisher
Aug 21, 2024

Who Is Jeff Bezos: History, Background, Achievements, and Net Worth - Investing.com

Aug 21, 2024
pulisher
Aug 20, 2024

Dr. Parag Mallick, PhDCo-Founder, Nautilus BiotechnologyUnlocking The Complexity Of The Proteome For A New Era Of Scientific Discovery - Audacy

Aug 20, 2024
pulisher
Aug 18, 2024

Nautilus Biotechnology Insider Ups Holding During Year - Yahoo Finance

Aug 18, 2024
pulisher
Aug 16, 2024

XPeng Inc. (NYSE:XPEV) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World

Aug 16, 2024
pulisher
Aug 16, 2024

Vanguard Group Inc. Acquires 29,604 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Aug 16, 2024
pulisher
Aug 14, 2024

Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - StockTitan

Aug 14, 2024
pulisher
Jul 31, 2024

Nautilus Biotechnology (NASDAQ:NAUT) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat

Jul 31, 2024
pulisher
Jul 31, 2024

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q2 2024 Earnings Call Transcript - Insider Monkey

Jul 31, 2024
pulisher
Jul 30, 2024

Nautilus Biotechnology, Inc. (NAUT) Q2 2024 Earnings Call Transcript - Seeking Alpha

Jul 30, 2024
pulisher
Jul 30, 2024

NAUT Stock Earnings: Nautilus Biotechnology Beats EPS for Q2 2024 - InvestorPlace

Jul 30, 2024
pulisher
Jul 30, 2024

Nautilus Down on Releasing Q2 Numbers - Baystreet.ca

Jul 30, 2024
pulisher
Jul 30, 2024

Nautilus Biotechnology Reports Second Quarter 2024 Financial Results - GlobeNewswire

Jul 30, 2024
pulisher
Jul 27, 2024

We're Not Very Worried About Nautilus Biotechnology's (NASDAQ:NAUT) Cash Burn Rate - Simply Wall St

Jul 27, 2024
pulisher
Jul 24, 2024

Hybrid Software Group PLC Publishes 2024 Interim Report - Yahoo Finance UK

Jul 24, 2024
pulisher
Jul 23, 2024

Nautilus Biotechnology (NAUT) Set to Announce Earnings on Tuesday - Defense World

Jul 23, 2024
pulisher
Jul 23, 2024

Nautilus Biotechnology (NAUT) to Release Earnings on Tuesday - MarketBeat

Jul 23, 2024

Finanzdaten der Nautilus Biotechnology Inc-Aktie (NAUT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Nautilus Biotechnology Inc-Aktie (NAUT) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Godwin Mary E.
Senior VP, Operations
Sep 23 '24
Sale
2.87
47,031
134,744
0
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):